R S Sloan

Author PubWeight™ 33.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis 1978 1.83
2 Multiple-dose ciprofloxacin kinetics in normal subjects. Clin Pharmacol Ther 1984 1.62
3 Overnight urine collections to estimate sodium intake. Hypertension 1983 1.58
4 Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1983 1.19
5 Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure. Antimicrob Agents Chemother 1977 1.18
6 Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother 1981 1.17
7 Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983 1.16
8 Recovery from aminoglycoside nephrotoxicity with continued drug administration. Antimicrob Agents Chemother 1978 1.12
9 Mezlocillin pharmacokinetics in renal impairment. Clin Pharmacol Ther 1980 1.05
10 Intra- and interindividual variability in sodium intake in normal subjects and in patients with renal insufficiency. Am J Kidney Dis 1986 1.04
11 Comparative nephrotoxicity of SCH 21420 and amikacin in rats. Antimicrob Agents Chemother 1979 1.02
12 Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function. J Infect Dis 1984 1.02
13 Moxalactam pharmacokinetics during hemodialysis. Antimicrob Agents Chemother 1981 1.02
14 Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983 1.00
15 Nephrotoxicity of netilmicin in combination with non-aminoglycoside antibiotics. Antimicrob Agents Chemother 1978 0.98
16 Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983 0.96
17 Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin Pharmacol Ther 1984 0.95
18 The effect of piperacillin dose on elimination kinetics in renal impairment. Eur J Clin Pharmacol 1983 0.94
19 Protection from gentamicin nephrotoxicity by cephalothin and carbenicillin. Antimicrob Agents Chemother 1979 0.93
20 Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis. Antimicrob Agents Chemother 1978 0.92
21 Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans. Hypertension 1985 0.91
22 The effect of dietary sodium and protein on urine volume and water intake. J Lab Clin Med 1983 0.90
23 Mezlocillin dose dependent elimination kinetics in renal impairment. Eur J Clin Pharmacol 1982 0.88
24 Nitrendipine kinetics in normal and impaired renal function. Clin Pharmacol Ther 1985 0.83
25 Influence of home monitoring on compliance with a reduced sodium intake diet. Arch Intern Med 1984 0.82
26 Pharmacokinetics of moxalactam in patients with normal and impaired renal function. J Infect Dis 1982 0.81
27 The utility of overnight urine collections in assessing compliance with a low sodium intake diet. JAMA 1983 0.81
28 Comparative low-dose nephrotoxicities of dibekacin, gentamicin, and tobramycin. J Antimicrob Chemother 1982 0.79
29 Mezlocillin kinetics in hepatic insufficiency. Clin Pharmacol Ther 1983 0.78
30 The treatment of anemia with low-dose recombinant human erythropoietin. Am J Nephrol 1990 0.78
31 Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function. Antimicrob Agents Chemother 1990 0.77
32 The efficacy of quantitative and qualitative chloride titrators in the estimation of human salt intake. Klin Wochenschr 1985 0.77
33 The effect of chloride-containing potassium supplements on chloride titrator estimates of dietary sodium intake. J Am Coll Nutr 1985 0.76
34 Short-term augmented calcium intake has no effect on sodium homeostasis. Clin Pharmacol Ther 1986 0.75
35 Immune complex nephritis in nude mice. Nephron 1981 0.75
36 Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients. Am J Kidney Dis 1991 0.75
37 Nizatidine disposition in subjects with normal and impaired renal function. Clin Pharmacol Ther 1988 0.75
38 Pharmacokinetics of cinoxacin in patients with renal failure. J Antimicrob Chemother 1978 0.75
39 Achieving compliance to a reduced sodium diet. Nurse Pract 1985 0.75
40 Determining specific gravity of urine with reagent sticks. Clin Chem 1984 0.75
41 Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction. Clin Pharmacol Ther 1995 0.75
42 Preventing sexual abuse of children: a model school education program. J Community Health Nurs 1984 0.75